A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to treatment, such as cognitive behavioral therapy and contingency management interventions, for a very serious condition that remains difficult to treat and overcome.
from Latest Science News -- ScienceDaily https://ift.tt/39tnB66
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment